Analyzing Ingalls & Snyder LLC’s Q3 Q4 2022 13F Holdings: Changes in Holdings and Investment Strategy

Investments are a crucial part of any financial strategy, and fund holdings provide a unique insight into how professionals are investing their money. Ingalls & Snyder LLC is a New York-based investment management firm founded in 1924 that manages over $6.9 billion in assets. The company recently filed its 13F holdings for Q3 2022 and Q4 2022. This article compares the changes in holdings of Ingalls & Snyder LLC for these two quarters.

The 13F filings released by Ingalls & Snyder LLC reveal the company's investment strategies and how they have changed over time. The quarterly filings show the company's holdings of publicly traded securities and the value of these holdings. The latest filings show that the company has a diverse portfolio consisting of stocks, options, and exchange-traded funds.

Looking at the data, we can see that Ingalls & Snyder LLC made significant changes in their holdings during the Q3 2022 to Q4 2022 period. The total value of the company's holdings decreased from $237,760,213 to $219,307,791, a decrease of 7.7%. The number of shares the company held also decreased from 35,821,158 to 35,740,264, a decrease of 0.2%.

One of the top holdings in Q3 was Corcept Therapeutics Inc. (CORT), with 6,951,077 shares valued at $178,226,000. However, in Q4, the company reduced its position in Corcept Therapeutics Inc. by 2.2%. The company's holdings in Pioneer Natural Resources Co. (PXD) decreased by 4.3% from Q3 to Q4, with the value of the holdings dropping from $108,972,000 to $113,638,000.

Ingalls & Snyder LLC increased its holdings in Canadian Natural Resources Ltd. (CNQ.TO) by 18.2% and Berkshire Hathaway Inc. Del. (BRK-B) by 12.2%. The company also increased its holdings in JPMorgan Chase & Co. (JPM) by 27.8% and Merck & Co. Inc. (MRK) by 25.5%. All these companies experienced an increase in value between Q3 and Q4.

But not all of the holdings fared well between Q3 and Q4. The company decreased its holdings in Globe Life Inc. (GL) by 20.8%, and its holdings in Disney Walt Co. (DIS) decreased by 26.6%. There were also significant decreases in the company's holdings of stocks such as PayPal Hldgs Inc. (PYPL) and Oracle Corp. (ORCL).

Ingalls & Snyder LLC also diversified its holdings in Q4 2022 by adding some new positions. The company purchased 5,057,725 shares of Meta Platforms Inc. (META), valued at $6,079,000. The company also picked up initial positions in Coterra Energy Inc. (CTRA) and ImmunoPrecise Antibodies Ltd. (IPA). The holdings in these new companies were valued at $5,281,000 and $5,054,000, respectively.

The company's top holdings in terms of value in Q4 were still Apple Inc. (AAPL), Alphabet Inc. (GOOGL), and Microsoft Corp. (MSFT), although the value of these stocks decreased between Q3 and Q4.

In conclusion, Ingalls & Snyder LLC made significant changes in its holdings between Q3 2022 and Q4 2022. The company reduced its holdings in some companies while increasing its holdings in others, showing a dynamic investment strategy. The company also diversified its holdings by adding positions in new companies. The quarterly filings provide an excellent insight into how professional investment managers stay agile in the face of changing market conditions.